tradingkey.logo
tradingkey.logo
Search

24H|Merus Surges 19%; Chinese ADRs Jump With Li Auto up 7%, Alibaba up 3%; Wolfspeed Drops Another 3%

TigerSep 29, 2025 2:14 AM
facebooktwitterlinkedin
View all comments(0)

Denmark’s Genmab A/S is in advanced talks to acquire Merus NV, a Dutch drugmaker that’s developing a treatment for cancer of the head and neck, according to people with knowledge of the matter, Bloomberg reported. US-listed Merus shares surged 19.1% in overnight trading.

Some Chinese ADRs jumped in overnight trading. Li Auto rose 7%; Alibaba rose 3%; Bilibili, NIO, and XPeng rose 2%; Trip.com, NetEase, JD.com, Baidu, and PDD Holdings rose 1%.

Wolfspeed is pushing forward with corporate restructuring while navigating bankruptcy court. The semiconductor company announced plans to convert from North Carolina to Delaware incorporation by September 29, 2025. The shares plunged 34.6% on Friday, and dropped another 3.3% in overnight trading.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.